Topic: The News & Observer Publishing Company

Tranzyme Plans Stock Offering

Drugs.com - 445 days ago
Tranzyme Plans Stock Offering [The News & Observer, Raleigh, N.C.]. Tranzyme filed IPO plans late Friday with the Securities and Exchange Commission. Tranzyme, led by CEO Vipin Garg since 2000, is testing a drug that could help hospitalized patients who have intestinal ...

Eisai Can Sell Breast-Cancer Drug

Drugs.com - 452 days ago
Eisai Can Sell Breast-Cancer Drug [The News & Observer, Raleigh, N.C.]. The drug, Halaven, is a synthetic form of a compound found in sea sponges that works by inhibiting cancer cell growth, the Food and Drug Administration wrote in a statement.. Eisai ...

Fitness or Fetish?

Suite 101 - 460 days ago
According to the World Health Organization, modernization, automation and globalization are shifting people (especially and middle and upper class) toward less and less physically demanding work. People with an active lifestyle should not have to feel guilty about eating a little extra ...

GSK Taps PPD As Key Ally

Drugs.com - 509 days ago
Sept. 18--GlaxoSmithKline has chosen two contract-research organizations to handle its future clinical drug development: PPD of Wilmington and Parexel International, based in Massachusetts. PPD is based in Wilmington and employs about 1,400 people in the Triangle. To see more of The ...

New Route To Killing Cancer Tried

Drugs.com - 597 days ago
June 24--A targeted therapy that has generated excitement for its early success in breast cancer is now being tested in the Triangle on other cancers, including often-deadly ovarian tumors.. Called PARP inhibitors, after the enzyme they target, the drugs disable a key ...

North American Boss at Sony Ericsson Quits

IT Business Edge - 1055 days ago
Sony Ericsson's head of operations in North America is leaving at the end of March to " com.. Najmi Jarwala, who has a Ph.D. in electrical and computer engineering, was brought in four years ago to beef up market share against ...